MRT Inc. (6034) AI Stock Analysis

• Market Cap: ¥3.97B
• Dividend Yield: N/A
• Average Volume (3M): 3.02K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.02
• Revenue Growth: -2.66%
• EPS Growth: -913.85%
• Country: JP
• Employees: 304
• Sector: Healthcare
• Sector Strength: 52
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 32.00
• Shares Outstanding: 5,718,600
• 10 Day Avg. Volume: 1,200
• 30 Day Avg. Volume: 3,016
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥720.00
• Price Target Upside: 1.12% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 52 Neutral
• Price Target: ¥720.00 ▲(1.12% Upside)

The overall stock score of 52 reflects significant financial challenges, including declining profitability and cash flow issues. Technical analysis provides some neutral to slightly positive signals, but valuation concerns due to negative earnings weigh heavily on the score. The absence of earnings call data and corporate events limits additional insights.

MRT Inc. Business Overview & Revenue Model

Company Description

MRT Inc. (6034) is a Japanese company specializing in the healthcare and medical sectors. The company is primarily involved in providing medical information services and operates platforms that connect medical professionals with the healthcare industry. MRT Inc. facilitates efficient communication and information exchange among healthcare practitioners, institutions, and patients.

How the Company Makes Money

MRT Inc. generates revenue through its digital platforms that offer a range of services including job placement and recruitment services for medical professionals, advertising and promotional services for healthcare products, and subscription fees for access to specialized medical information. The company partners with healthcare institutions, medical device manufacturers, and pharmaceutical companies to create a robust ecosystem that supports its monetization strategies. Additional revenue streams may include consulting and support services tailored to the needs of healthcare providers.

MRT Inc. Financial Statement Overview

Summary

MRT Inc. is facing financial difficulties with declining revenue and profitability. The income statement shows negative net profit and EBIT margins, and cash flow analysis reveals a significant decline in free cash flow growth. The balance sheet is stable but profitability issues persist.

Income Statement

MRT Inc. shows a concerning decline in revenue and profitability over the recent periods. The TTM data indicates a negative net profit margin of -8.26%, and EBIT margin of -4.15%, reflecting operational challenges. Despite a slight revenue growth of 1.11% in the TTM, the company has faced significant revenue declines in prior years, impacting overall performance.

Balance Sheet

The balance sheet reflects a moderate debt-to-equity ratio of 0.16 in the TTM, indicating manageable leverage. However, the return on equity is negative at -7.77%, highlighting profitability issues. The equity ratio remains stable, suggesting a solid capital structure despite recent financial challenges.

Cash Flow

Cash flow analysis reveals a significant decline in free cash flow growth at -56.11% in the TTM, raising concerns about cash generation capabilities. The operating cash flow to net income ratio is 0.58, indicating some operational cash flow support, but overall cash flow performance has weakened.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	4.27B	4.17B	5.41B	8.74B	4.47B	2.56B
Gross Profit	2.75B	2.74B	3.27B	5.60B	3.55B	1.76B
EBITDA	174.66M	139.00M	1.10B	3.16B	1.45B	420.18M
Net Income	-265.63M	-309.16M	517.00M	2.16B	774.49M	131.81M
Balance Sheet
Total Assets	6.29B	6.75B	6.47B	8.16B	4.98B	3.31B
Cash, Cash Equivalents and Short-Term Investments	2.19B	2.62B	3.78B	4.90B	1.03B	1.59B
Total Debt	646.35M	1.05B	641.00M	875.86M	1.04B	1.11B
Total Liabilities	1.79B	2.12B	1.76B	3.67B	2.69B	1.75B
Stockholders Equity	4.39B	4.52B	4.58B	4.39B	2.22B	1.52B
Cash Flow
Free Cash Flow	214.58M	462.00M	-208.00M	4.43B	-405.64M	183.97M
Operating Cash Flow	231.74M	503.04M	-193.00M	4.51B	-298.89M	294.97M
Investing Cash Flow	-2.00B	-1.84B	-243.61M	-431.11M	-206.51M	-64.61M
Financing Cash Flow	-194.10M	161.77M	-669.19M	-203.98M	-67.49M	-397.41M

MRT Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 712.00
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6034, the sentiment is Positive. The current price of 712 is below the 20-day moving average (MA) of 712.65, above the 50-day MA of 709.90, and above the 200-day MA of 710.16, indicating a neutral trend. The MACD of 0.57 indicates Positive momentum. The RSI at 50.42 is Neutral, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6034.

MRT Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3671	85 Outperform	¥7.65B	11.81		9.43%	26.12%	38.78%
6545	68 Neutral	¥3.39B	15.12		1.90%	5.27%	12.22%
6034	52 Neutral	¥3.97B	―		―	-2.66%	-913.85%
Sector *	51 Neutral	$7.95B	-0.40	-42.50%	2.21%	22.29%	-1.85%
4438	44 Neutral	¥2.71B	―		―	15.50%	-31.31%
3902	43 Neutral	¥23.28B	4,465.71		1.09%	-0.58%	-260.22%
3628	40 Neutral	¥6.72B	―		―	-2.60%	-103.03%